1. Home
  2. TMDX vs RVT Comparison

TMDX vs RVT Comparison

Compare TMDX & RVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • RVT
  • Stock Information
  • Founded
  • TMDX 1998
  • RVT 1986
  • Country
  • TMDX United States
  • RVT United States
  • Employees
  • TMDX N/A
  • RVT N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RVT Trusts Except Educational Religious and Charitable
  • Sector
  • TMDX Health Care
  • RVT Finance
  • Exchange
  • TMDX Nasdaq
  • RVT Nasdaq
  • Market Cap
  • TMDX 2.3B
  • RVT 1.9B
  • IPO Year
  • TMDX 2019
  • RVT N/A
  • Fundamental
  • Price
  • TMDX $127.12
  • RVT $14.84
  • Analyst Decision
  • TMDX Buy
  • RVT
  • Analyst Count
  • TMDX 10
  • RVT 0
  • Target Price
  • TMDX $122.89
  • RVT N/A
  • AVG Volume (30 Days)
  • TMDX 1.2M
  • RVT 243.4K
  • Earning Date
  • TMDX 05-08-2025
  • RVT 01-01-0001
  • Dividend Yield
  • TMDX N/A
  • RVT 7.32%
  • EPS Growth
  • TMDX N/A
  • RVT N/A
  • EPS
  • TMDX 1.41
  • RVT 2.95
  • Revenue
  • TMDX $488,227,000.00
  • RVT N/A
  • Revenue This Year
  • TMDX $32.58
  • RVT N/A
  • Revenue Next Year
  • TMDX $21.65
  • RVT N/A
  • P/E Ratio
  • TMDX $90.23
  • RVT $4.98
  • Revenue Growth
  • TMDX 64.43
  • RVT N/A
  • 52 Week Low
  • TMDX $55.00
  • RVT $11.85
  • 52 Week High
  • TMDX $177.37
  • RVT $14.93
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 76.52
  • RVT 57.19
  • Support Level
  • TMDX $118.79
  • RVT $14.42
  • Resistance Level
  • TMDX $130.48
  • RVT $15.05
  • Average True Range (ATR)
  • TMDX 4.49
  • RVT 0.22
  • MACD
  • TMDX -0.15
  • RVT -0.02
  • Stochastic Oscillator
  • TMDX 83.53
  • RVT 58.33

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About RVT Royce Value Trust Inc.

Royce Value Trust Inc is a diversified closed-end investment company. It invests in diversified sectors including consumer discretionary, consumer staples, healthcare, financial, IT, telecommunications, and materials. The company's portfolio includes common stocks, preferred stocks, corporate bonds, and repurchase agreements.

Share on Social Networks: